PE20000119A1 - Nuevos derivados de la eritromicina - Google Patents

Nuevos derivados de la eritromicina

Info

Publication number
PE20000119A1
PE20000119A1 PE1998001285A PE00128598A PE20000119A1 PE 20000119 A1 PE20000119 A1 PE 20000119A1 PE 1998001285 A PE1998001285 A PE 1998001285A PE 00128598 A PE00128598 A PE 00128598A PE 20000119 A1 PE20000119 A1 PE 20000119A1
Authority
PE
Peru
Prior art keywords
alkyl
refers
formula
compound
erythromycin
Prior art date
Application number
PE1998001285A
Other languages
English (en)
Inventor
Yong-Jin Wu
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PE20000119A1 publication Critical patent/PE20000119A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

SE REFIERE A DERIVADOS DE ERITROMICINA DE FORMULA I, DONDE R ES ALQUILO C3-C8RAMIFICADO EN ALFA, ALQUENILO, ALQUINILO, ALCOXIALQUILO, ALQUILTIOALQUILO, FENILO OPCIONALMENTE SUSTITUIDO, GRUPO DE FORMULA a, CH2R24; R24 ES H, ALQUILO C1-C8, ALQUENILO C2-C8, ENTRE OTROS; X1 ES O, S, -CH2-; a, b, c Y d SON 0-2 Y a+b+c+d¾5; R4 ES H o ACILO DE UN ACIDO ORGANICO DE HASTA 18 CARBONOS. TAMBIEN SE REFIERE A COMPUESTOS DE FORMULA II, DONDE X ES -(CR5R6)g-, NR5; g ES 0-1; CUANDO X ES -NR5-, X Y R3 JUNTOS FORMAN UN HETEROCICLO DE FORMULA b; n Y p SON 1-3; q ES 0 o 1; R9 ES CH2, O, S, C=O, S=O, SO2, ENTRE OTROS; TAMBIEN SE REFIERE A PROCEDIMIENTOS PARA LA PREPARACION DEL COMPUESTO I, II Y COMPUESTOS INTERMEDIARIOS. EL COMPUESTO I PUEDE SER UTIL PARA EL TRATAMIENTO DE UNA INFECCION BACTERIANA O DE UNA INFECCION PROTOZOARIA Y OTRAS APLICACIONES COMO ANTICANCERIGENO, ATEROESCLEROSIS, REDUCCION DE LA MOTILIDAD GASTRICA
PE1998001285A 1998-01-02 1998-12-28 Nuevos derivados de la eritromicina PE20000119A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7035898P 1998-01-02 1998-01-02

Publications (1)

Publication Number Publication Date
PE20000119A1 true PE20000119A1 (es) 2000-02-17

Family

ID=22094819

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998001285A PE20000119A1 (es) 1998-01-02 1998-12-28 Nuevos derivados de la eritromicina

Country Status (36)

Country Link
US (1) US6825171B2 (es)
EP (2) EP1642901B1 (es)
JP (1) JP2002500231A (es)
KR (1) KR20010033822A (es)
CN (1) CN1285841A (es)
AP (1) AP1060A (es)
AR (5) AR012764A1 (es)
AT (1) ATE377018T1 (es)
AU (1) AU759019B2 (es)
BG (1) BG104640A (es)
BR (1) BR9812992A (es)
CA (1) CA2317131C (es)
CO (1) CO4970773A1 (es)
CZ (1) CZ20002456A3 (es)
DE (1) DE69838651T9 (es)
DZ (1) DZ2699A1 (es)
EA (1) EA200000600A1 (es)
ES (1) ES2294641T3 (es)
GT (1) GT199800207A (es)
HR (1) HRP20000444A2 (es)
HU (1) HUP0100566A3 (es)
IL (1) IL136721A0 (es)
IS (1) IS5527A (es)
MA (1) MA26588A1 (es)
NO (1) NO20003346L (es)
NZ (1) NZ504987A (es)
OA (1) OA11440A (es)
PA (1) PA8465901A1 (es)
PE (1) PE20000119A1 (es)
PL (1) PL341647A1 (es)
SK (1) SK9772000A3 (es)
TN (1) TNSN98236A1 (es)
UY (2) UY25331A1 (es)
WO (1) WO1999035157A1 (es)
YU (1) YU40900A (es)
ZA (1) ZA9811940B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
AP9801420A0 (en) 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
GB9814006D0 (en) 1998-06-29 1998-08-26 Biotica Tech Ltd Polyketides and their synthesis
EP1749832A3 (en) * 1998-12-10 2008-03-26 Pfizer Products Incorporated Carbamate and carbazate ketolide antibiotics
EP1137654A1 (en) 1998-12-10 2001-10-04 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
SI1147121T1 (en) 1999-01-27 2004-04-30 Pfizer Products Inc. Ketolide antibiotics
EP1754700A3 (en) 1999-01-27 2007-05-09 Kosan Biosciences, Inc. Synthesis of oligoketides
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
MXPA01010524A (es) 1999-04-16 2002-03-14 Kosan Biosciences Inc Agentes macrolidos anti-infecciosos.
US6399582B1 (en) 1999-04-16 2002-06-04 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
EE200100613A (et) * 1999-05-24 2003-02-17 Pfizer Products Inc. 13-metüülerütromütsiini derivaadid
ID27331A (id) * 1999-09-29 2001-03-29 Pfizer Prod Inc Pembuatan antibiotik-antibiotik ketolida karbamat
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
WO2001060833A2 (en) 2000-02-18 2001-08-23 Kosan Biosciences, Inc. Motilide compounds
US20020115621A1 (en) 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
US6472372B1 (en) 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
CA2451391A1 (en) 2001-07-03 2003-01-16 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
EP1430068A1 (en) 2001-09-17 2004-06-23 Ortho-Mcneil Pharmaceutical, Inc. 6-o-carbamate-11,12-lacto-ketolide antimicrobials
PL370714A1 (en) 2001-12-05 2005-05-30 Ortho-Mcneil Pharmaceutical, Inc. 6-o-acyl ketolide derivatives of erythromycine useful as antibacterials
AU2003234650A1 (en) 2002-05-31 2003-12-19 Janssen Pharmaceutica N.V. 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents
JP2006524706A (ja) 2003-04-25 2006-11-02 カイロン コーポレイション 新規なケトライド誘導体
AP2007004026A0 (en) 2004-12-21 2007-06-30 Pfizer Prod Inc Macrolides
CN101568343A (zh) 2006-06-12 2009-10-28 雷蒙特亚特特拉维夫大学有限公司 用于治疗癌症的方法
EP2934548A2 (en) 2012-12-24 2015-10-28 Ramot at Tel-Aviv University Ltd Agents for treating genetic diseases resulting from nonsense mutations, and methods for identifying the same

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US77302A (en) * 1868-04-28 mat son
US61857A (en) * 1867-02-05 Improvement in top-drivers or spinners
US61856A (en) * 1867-02-05 Enos s
US100518A (en) * 1870-03-08 Roland s
US156027A (en) * 1874-10-20 Improvement in loom-shuttles
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
AU1142383A (en) 1982-04-26 1983-11-03 Shakas, P.V. Infant transitional sensory system
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4998097A (en) 1983-07-11 1991-03-05 Square D Company Mechanically operated pressure switch having solid state components
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
US4585759A (en) * 1985-01-22 1986-04-29 Pfizer Inc. Antibacterial derivatives of a neutral macrolide
JPS61229895A (ja) * 1985-04-03 1986-10-14 Nippon Zeon Co Ltd 保護化デス−ｎ−メチルエリスロマイシン誘導体
ES8800986A1 (es) 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
US4672056A (en) * 1985-11-12 1987-06-09 Abbott Laboratories Erythromycin A derivatives and method of use
JPH0633312B2 (ja) 1986-05-02 1994-05-02 大正製薬株式会社 １４−ハイドロキシエリスロマイシン誘導体およびその製造方法
EP0283055B1 (en) * 1987-09-03 1990-08-29 SOUR PLIVA farmaceutska, Kemijska prehrambena i kozmeticka industrija, n.sol.o. 10-dihydro-10-deoxo-11-azaerythronolide-a-compounds, methods and intermediates for the manufacture thereof and their use in pharmaceuticals and in the manufacture thereof
GB8726730D0 (en) 1987-11-14 1987-12-16 Pfizer Ltd Antiparasitic agents
GB8815967D0 (en) 1988-07-05 1988-08-10 Pfizer Ltd Antiparasitic agents
US4934897A (en) 1989-02-23 1990-06-19 J. I. Case Company Pipe-moving apparatus
US5141926A (en) 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
WO1993013663A1 (en) 1992-01-17 1993-07-22 Abbott Laboratories Method of directing biosynthesis of specific polyketides
US6060234A (en) * 1991-01-17 2000-05-09 Abbott Laboratories Polyketide derivatives and recombinant methods for making same
US5824513A (en) * 1991-01-17 1998-10-20 Abbott Laboratories Recombinant DNA method for producing erythromycin analogs
JP3286941B2 (ja) * 1991-07-09 2002-05-27 株式会社日立製作所 ダイヤモンド研削砥石のツルーイング法
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
FR2691464B1 (fr) 1992-05-21 1995-06-02 Roussel Uclaf Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments.
FR2692579B1 (fr) * 1992-06-19 1995-06-02 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
US6066721A (en) * 1995-07-06 2000-05-23 Stanford University Method to produce novel polyketides
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5486697A (en) 1994-11-14 1996-01-23 California Institute Of Technology Array of micro-machined mass energy micro-filters for charged particles
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2732684B1 (fr) * 1995-04-06 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US5801032A (en) 1995-08-03 1998-09-01 Abbott Laboratories Vectors and process for producing high purity 6,12-dideoxyerythromycin A by fermentation
WO1997008266A1 (en) 1995-08-22 1997-03-06 Mobil Oil Corporation Visbreaking process using plastics as co-feed
ES2218604T3 (es) 1995-11-08 2004-11-16 Abbott Laboratories Derivados triciclicos de eritromicina.
US6077943A (en) * 1996-03-01 2000-06-20 Takeda Chemical Industries, Ltd. Method of producing erythromycin derivative
US5719272A (en) * 1996-04-02 1998-02-17 Abbott Laboratories 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
JP2000511063A (ja) 1996-07-05 2000-08-29 バイオティカ テクノロジー リミティド ポリケチド類及びそれらの合成
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
CN100441591C (zh) * 1996-09-04 2008-12-10 艾博特公司 酮基内酯类化合物，其用途和制备方法以及药用组合物
FR2754821B1 (fr) 1996-10-23 2003-04-04 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
NL1006540C2 (nl) 1997-07-10 1999-01-15 Skf Ind Trading & Dev Elektrische actuator met regelsensor, alsmede schijfrem omvattende een dergelijke actuator.
EP1662423A3 (en) 1997-08-28 2006-08-02 Supersensor (Proprietary) Limited Reader arrangement for an electronic identification system
US6034069A (en) * 1997-09-30 2000-03-07 Abbott Laboratories 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
AP9801420A0 (en) 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
DE69919769T2 (de) * 1998-03-03 2005-01-27 Pfizer Products Inc., Groton 3,6-Ketal-Makrolidantibiotika
US5975370A (en) * 1998-03-16 1999-11-02 Owens-Illinois Closure Inc. Tamper-evident plunger-hold-down attachment for pump dispenser
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
US6262030B1 (en) * 1998-11-03 2001-07-17 Pfizer Inc. Erythromycin derivatives
SI1147121T1 (en) 1999-01-27 2004-04-30 Pfizer Products Inc. Ketolide antibiotics
CA2361590C (en) 1999-02-05 2011-03-22 Rina Das Method of diagnosing of exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes
US6399582B1 (en) * 1999-04-16 2002-06-04 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
MXPA01010524A (es) * 1999-04-16 2002-03-14 Kosan Biosciences Inc Agentes macrolidos anti-infecciosos.
US20020077302A1 (en) 1999-04-23 2002-06-20 Yong-Jin Wu Tricyclic erythromycin derivatives
US20020061857A1 (en) 1999-04-23 2002-05-23 Yong-Jin Wu 9-amino-3-oxo erythromycin derivatives
EE200100613A (et) 1999-05-24 2003-02-17 Pfizer Products Inc. 13-metüülerütromütsiini derivaadid
EP1101769A3 (en) * 1999-11-18 2001-10-24 Pfizer Products Inc. Nitrogen containing erythromycin derivatives
US20020061856A1 (en) 2000-04-24 2002-05-23 Yong-Jin Wu Novel tricyclic erythromycin derivatives
JP2005050903A (ja) 2003-07-30 2005-02-24 Toshiba Corp 半導体装置およびその製造方法

Also Published As

Publication number Publication date
AP9801421A0 (en) 1998-12-31
EP1642901A1 (en) 2006-04-05
CZ20002456A3 (cs) 2001-09-12
AR019788A2 (es) 2002-03-13
BR9812992A (pt) 2000-10-17
KR20010033822A (ko) 2001-04-25
HUP0100566A3 (en) 2003-07-28
ZA9811940B (en) 2000-06-30
NO20003346L (no) 2000-08-29
AR019789A2 (es) 2002-03-13
ATE377018T1 (de) 2007-11-15
US6825171B2 (en) 2004-11-30
US20040067897A1 (en) 2004-04-08
AR019790A2 (es) 2002-03-13
ES2294641T3 (es) 2008-04-01
HUP0100566A2 (hu) 2001-07-30
YU40900A (sh) 2003-01-31
CA2317131C (en) 2004-11-02
OA11440A (en) 2004-04-28
AR012764A1 (es) 2000-11-08
IS5527A (is) 2000-06-09
EA200000600A1 (ru) 2001-02-26
CO4970773A1 (es) 2000-11-07
NZ504987A (en) 2002-11-26
PL341647A1 (en) 2001-04-23
AU1501599A (en) 1999-07-26
DZ2699A1 (fr) 2003-03-29
CN1285841A (zh) 2001-02-28
AU759019B2 (en) 2003-04-03
WO1999035157A1 (en) 1999-07-15
UY25587A1 (es) 1999-09-27
JP2002500231A (ja) 2002-01-08
GT199800207A (es) 2000-06-22
CA2317131A1 (en) 1999-07-15
UY25331A1 (es) 2000-12-29
IL136721A0 (en) 2001-06-14
NO20003346D0 (no) 2000-06-27
EP1044208A1 (en) 2000-10-18
SK9772000A3 (en) 2002-09-10
MA26588A1 (fr) 2004-12-20
BG104640A (en) 2001-09-28
HRP20000444A2 (en) 2001-04-30
EP1642901B1 (en) 2007-10-31
AP1060A (en) 2002-04-23
DE69838651T2 (de) 2008-03-06
AR020016A2 (es) 2002-03-27
DE69838651T9 (de) 2008-06-12
TNSN98236A1 (fr) 2005-03-15
PA8465901A1 (es) 2000-09-29
DE69838651D1 (de) 2007-12-13
WO1999035157B1 (en) 1999-10-14

Similar Documents

Publication Publication Date Title
PE20000119A1 (es) Nuevos derivados de la eritromicina
PE20000049A1 (es) Nuevos macrolidos
RU2363700C2 (ru) Производные хинуклидина и фармацевтические композиции, содержащие их
ES2056913T3 (es) Derivados heterociclicos n-substituidos por el grupo benzhidrilo; su preparacion y su aplicacion.
PE20020056A1 (es) Fenil amidas para-aril o heteroaril sustituidas como activadores de la glucoquinasa
AR027117A1 (es) Trifluorometilpirrolcarboxamidas y trifluorometilpirroltioamidas como fungicidas
ES2076147T3 (es) Nuevos derivados de amina ciclicos, medicamento que contiene estos compuestos y procedimiento para su preparacion.
DK633088A (da) Kollagenaseinhibitorer
AR023152A1 (es) Compuesto tienopirimidina, procedimiento para producirlo, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar dichacomposicion
AR026990A1 (es) Antagonistas de neurokinina selectivos
SE8106125L (sv) 4,5-polymetylen-4-isotiazolin-3-oner, sett for framstellning derav och anvendning derav som baktericida och fungicida medel
GB1046506A (en) Guanidine compounds and process for their manufacture
DK0479546T3 (da) Piperazinderivater
SE7602144L (sv) Kvaternera imidazoliumforeningar
KR930002311A (ko) N-페닐티오우레아 유도체 및 그의 약학적 용도
PE20040750A1 (es) Derivados de n-(1-acetilpiperidin-4-il)-4-benzidril-2-isopropilpiperazin-1-carboxamida como inhibidores de 17beta-hidroxiesteroide deshidrogenasa de tipo 3
KR900014396A (ko) 티에노-트리아졸로-디아제핀 유도체, 그의 제조 방법 및 그를 함유하는 치료 조성물
GB8613591D0 (en) Chemical compounds
ES2040856T3 (es) Un procedimiento para preparar un compuesto de tiofeno.
ATE35413T1 (de) Cephalosporinverbindungen und ihre herstellung.
AR012847A1 (es) Compuestos derivados de eritromicina, composiciones farmaceuticas, procedimientos de tratamiento con dichos compuestos, procedimiento parapreparar dichos compuestos
SE7408320L (es)
KR850007590A (ko) 4-(니트로페닐)-테트라히드로피리딘류의 제조방법
EA200200569A1 (ru) Арилоксипропаноламины для улучшения продуктивности домашнего скота
KR910015537A (ko) 신규 1-아릴술포닐-2-피페리디논 유도체, 이의 제조방법, 제조용 중간체, 의약품으로서의 용도 및 이 화합물을 함유하는 조성물

Legal Events

Date Code Title Description
FC Refusal